|
IL36670A
(en)
|
1971-04-21 |
1974-09-10 |
Sela M |
Therapeutic basic copolymers of amino acids
|
|
US3723506A
(en)
|
1971-08-11 |
1973-03-27 |
Univ Sherbrooke |
Oxidation of sugars
|
|
DE2917104A1
(de)
|
1979-04-27 |
1980-11-06 |
Hoechst Ag |
Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
|
|
JPS56128721A
(en)
|
1980-03-12 |
1981-10-08 |
Eisai Co Ltd |
Antiallergic agent
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
JPS60501259A
(ja)
|
1983-05-06 |
1985-08-08 |
ウイスコンシン・アルムニ・リサ−チ・フアンデ−シヨン |
免疫刺激活性をもつ単糖類化合物
|
|
JPS618945A
(ja)
|
1984-06-25 |
1986-01-16 |
Nec Corp |
半導体集積回路装置
|
|
SE456346B
(sv)
|
1984-07-23 |
1988-09-26 |
Pharmacia Ab |
Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
|
|
US4619995A
(en)
|
1984-12-24 |
1986-10-28 |
Nova Chem Limited |
N,O-carboxymethyl chitosan and preparative method therefor
|
|
AU590599B2
(en)
|
1985-07-12 |
1989-11-09 |
New York University |
Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
|
|
US4684727A
(en)
|
1985-07-29 |
1987-08-04 |
Schering Corporation |
Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
|
|
AU7232087A
(en)
|
1986-03-26 |
1987-10-20 |
Genexpress Aps |
Biological containment
|
|
US4775626A
(en)
|
1986-05-23 |
1988-10-04 |
Syntex (U.S.A.) Inc. |
Method and compositions for protecting anerobic microorganisms
|
|
US4819617A
(en)
|
1986-09-04 |
1989-04-11 |
University Of Florida |
Viscoelastic material for ophthalmic surgery
|
|
US5514581A
(en)
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
|
DE3704389A1
(de)
|
1987-02-12 |
1988-08-25 |
Blutspendedienst Dt Rote Kreuz |
Verfahren zur herstellung von lymphokinen durch induktion lymphoider zellen
|
|
US4835252A
(en)
|
1987-02-26 |
1989-05-30 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Vasoactive intestinal peptide analogs
|
|
US5215896A
(en)
|
1987-03-20 |
1993-06-01 |
Creative Biomolecules, Inc. |
Leader sequences for the production of recombinant proteins
|
|
US6174999B1
(en)
|
1987-09-18 |
2001-01-16 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
|
US4937270A
(en)
|
1987-09-18 |
1990-06-26 |
Genzyme Corporation |
Water insoluble derivatives of hyaluronic acid
|
|
US5140016A
(en)
|
1988-05-31 |
1992-08-18 |
University Of Florida |
Method and composition for preventing surgical adhesions using a dilute solution of polymer
|
|
US5126141A
(en)
|
1988-11-16 |
1992-06-30 |
Mediventures Incorporated |
Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
|
|
DE3840044A1
(de)
|
1988-11-27 |
1990-06-07 |
Behringwerke Ag |
Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
|
|
US5196510A
(en)
|
1988-12-29 |
1993-03-23 |
Cytogen Corporation |
Molecular recognition units
|
|
FI895708A7
(fi)
|
1989-02-10 |
1990-08-11 |
Alko Ab Oy |
Vesiliukoinen hajoamistuote
|
|
US4952524A
(en)
|
1989-05-05 |
1990-08-28 |
At&T Bell Laboratories |
Semiconductor device manufacture including trench formation
|
|
US5158939A
(en)
|
1989-07-21 |
1992-10-27 |
Wisconsin Alumni Research Foundation |
Method of stimulating the immune systems of animals and compositions useful therefor
|
|
RO111416B1
(ro)
|
1989-12-14 |
1996-10-31 |
Ca Nat Research Council |
Polizaharide modificate de neisseria meningitidis si e coli, combinatii antigenice si metoda de imunizare
|
|
US5268454A
(en)
|
1991-02-08 |
1993-12-07 |
La Jolla Pharmaceutical Company |
Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
|
|
US5130417A
(en)
|
1990-04-30 |
1992-07-14 |
Washington University |
Entamoeba histolytical immunogenic protein and cdna clone
|
|
US5331573A
(en)
|
1990-12-14 |
1994-07-19 |
Balaji Vitukudi N |
Method of design of compounds that mimic conformational features of selected peptides
|
|
KR940006696B1
(ko)
|
1991-01-16 |
1994-07-25 |
금성일렉트론 주식회사 |
반도체 소자의 격리막 형성방법
|
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
|
GB2254083A
(en)
|
1991-03-28 |
1992-09-30 |
Italfarmaco Spa |
Anticoagulants from e.coli saccharide
|
|
GR920100122A
(el)
|
1991-04-05 |
1993-03-16 |
Ethicon Inc |
Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.
|
|
US5605938A
(en)
|
1991-05-31 |
1997-02-25 |
Gliatech, Inc. |
Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
|
|
US5705178A
(en)
|
1991-05-31 |
1998-01-06 |
Gliatech, Inc. |
Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
|
|
US5936076A
(en)
|
1991-08-29 |
1999-08-10 |
Kirin Beer Kabushiki Kaisha |
αgalactosylceramide derivatives
|
|
US20050181021A1
(en)
|
1992-02-14 |
2005-08-18 |
Robert Lamb |
Vitamin E phosphate/phosphatidycholine liposomes to protect from or ameliorate cell damage
|
|
US5350941A
(en)
|
1992-09-23 |
1994-09-27 |
Texas Instruments Incorporated |
Trench isolation structure having a trench formed in a LOCOS structure and a channel stop region on the sidewalls of the trench
|
|
DE69330464T2
(de)
|
1992-09-24 |
2001-11-08 |
Brigham And Women's Hospital, Boston |
Gruppe b streptococcus typ ii und typ v polysaccharid-protein konjugate als impfstoffe
|
|
US5433794A
(en)
|
1992-12-10 |
1995-07-18 |
Micron Technology, Inc. |
Spacers used to form isolation trenches with improved corners
|
|
US5728385A
(en)
|
1993-08-12 |
1998-03-17 |
Classen Immunotherapies, Inc. |
Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
|
|
US5705335A
(en)
|
1993-11-26 |
1998-01-06 |
Hendry; Lawrence B. |
Design of drugs involving receptor-ligand-DNA interactions
|
|
IL113812A
(en)
|
1994-05-24 |
2000-06-29 |
Yeda Res & Dev |
Copolymer-1 pharmaceutical compositions containing it and its use
|
|
JPH07326664A
(ja)
|
1994-05-31 |
1995-12-12 |
Fuji Electric Co Ltd |
ウエハの誘電体分離溝の充填方法
|
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
|
US5679654A
(en)
|
1994-09-02 |
1997-10-21 |
Brigham & Women's Hospital, Inc. |
Capsular polysaccharide immunomodulator
|
|
US5700787A
(en)
|
1994-09-02 |
1997-12-23 |
Brigham & Women's Hospital, Inc. |
Capsular polysaccharide immunomodulator
|
|
CA2204355C
(en)
|
1994-11-02 |
2001-01-16 |
Gail Mandel |
Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
|
|
US5858964A
(en)
|
1995-04-14 |
1999-01-12 |
Yeda Research And Development Co. Ltd. |
Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD
|
|
US5679658A
(en)
|
1995-05-08 |
1997-10-21 |
Chitogenics, Inc. |
N,O-carbonxymethylchitosan for prevention of surgical adhesions
|
|
US5851808A
(en)
|
1997-02-28 |
1998-12-22 |
Baylor College Of Medicine |
Rapid subcloning using site-specific recombination
|
|
JP2001519817A
(ja)
|
1997-03-26 |
2001-10-23 |
ブリガム アンド ウイメンズ ホスピタル |
糖断片生成法
|
|
ATE229038T1
(de)
|
1997-04-04 |
2002-12-15 |
Fidia Advanced Biopolymers Srl |
N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung
|
|
US6749831B1
(en)
|
1997-05-16 |
2004-06-15 |
Medical Defense Technology, Llc |
Vaccine against lipopolysaccharide core
|
|
US5929049A
(en)
|
1997-08-08 |
1999-07-27 |
Dade Behring Marburg Gmbh |
Polysaccharide conjugates of biomolecules
|
|
EP0908179A1
(en)
|
1997-08-23 |
1999-04-14 |
Werner Bollag |
Treatment of cell-mediated immune diseases
|
|
US6015787A
(en)
|
1997-11-04 |
2000-01-18 |
New England Medical Center Hospitals, Inc. |
Cell-permeable protein inhibitors of calpain
|
|
EP1061949B1
(en)
|
1998-03-03 |
2009-07-15 |
University of Southern California |
Cytokines and mitogens to inhibit graft-versus-host disease
|
|
WO1999052560A1
(en)
|
1998-04-13 |
1999-10-21 |
Massachusetts Institute Of Technology |
Comb copolymers for regulating cell-surface interactions
|
|
ITPD980169A1
(it)
|
1998-07-06 |
2000-01-06 |
Fidia Advanced Biopolymers Srl |
Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
|
|
CA2366895A1
(en)
|
1999-04-02 |
2000-10-12 |
Brigham And Women's Hospital, Inc. |
Immunomodulating polymers
|
|
EP1459757A1
(en)
|
1999-04-02 |
2004-09-22 |
The Brigham And Women's Hospital, Inc. |
Immunomodulating polymers
|
|
US7083777B1
(en)
|
1999-04-02 |
2006-08-01 |
The Brigham And Women's Hospital, Inc. |
Immunomodulating polymers
|
|
JP2001055335A
(ja)
|
1999-08-18 |
2001-02-27 |
Toshio Sato |
アレルギー性皮膚疾患治療剤
|
|
US6995237B1
(en)
|
1999-10-27 |
2006-02-07 |
Cel-Sci Corporation |
Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions
|
|
US6358939B1
(en)
|
1999-12-21 |
2002-03-19 |
Northern Lights Pharmaceuticals, Llc |
Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
|
|
EP1303285A2
(en)
|
2000-07-17 |
2003-04-23 |
Chr. Hansen A/S |
Methods and formulations with probiotic microorganisms and medicaments
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US6670146B2
(en)
|
2000-10-04 |
2003-12-30 |
Schering Corporation |
Regulatory T cells; methods
|
|
SV2003000753A
(es)
|
2000-12-05 |
2003-06-16 |
Brigham & Womens Hospital |
Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
|
|
WO2002055091A1
(fr)
|
2001-01-12 |
2002-07-18 |
Amato Pharmaceutical Products,Ltd. |
Agents antiallergiques
|
|
WO2002064110A2
(en)
|
2001-02-13 |
2002-08-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Carotenoid-loaded liposomes
|
|
EP1372706B1
(en)
|
2001-03-09 |
2010-12-01 |
ID Biomedical Corporation of Quebec |
Proteosome-liposaccharide vaccine adjuvant
|
|
US20050101012A1
(en)
|
2001-03-12 |
2005-05-12 |
Gerold Schuler |
CD4+CD25+ regulatory T cells from human blood
|
|
NZ530635A
(en)
|
2001-06-15 |
2007-03-30 |
Nordic Vaccine Technology As |
Therapeutical vaccination comprising an immunogen and a targeting vehicle comprising a carrier and a antigen silmilar to the first
|
|
EP1308167A1
(de)
|
2001-11-06 |
2003-05-07 |
Pickl, Winfried, Ao. Univ. Prof. Dr. |
Antigenpräsentierende Vesikel
|
|
GB0130123D0
(en)
|
2001-12-17 |
2002-02-06 |
Microbiological Res Agency |
Outer membrane vesicle vaccine and its preparation
|
|
US20030147865A1
(en)
|
2002-02-07 |
2003-08-07 |
Benoit Salomon |
Cell therapy using immunoregulatory T-cells
|
|
DE60325696D1
(de)
*
|
2002-02-22 |
2009-02-26 |
Ca Nat Research Council |
Synthese von lipopolysaccharid-protein konjugatvaccinen über die lipid-a region nach entfernung des glycosidischen phosphatresidüs
|
|
EP1494687A2
(en)
|
2002-03-08 |
2005-01-12 |
Eli Lilly And Company |
Immunomodulatory polymeric antigens for treating inflammatory pathogies
|
|
US7166455B2
(en)
|
2002-03-13 |
2007-01-23 |
The Brigham And Women's Hospital, Inc. |
Method for overexpression of zwitterionic polysaccharides
|
|
US7829289B2
(en)
|
2002-05-14 |
2010-11-09 |
Institut National De La Sante Et De Recherche Medicale |
T cell subpopulation regulating gut immunity
|
|
GB0213622D0
(en)
|
2002-06-13 |
2002-07-24 |
Glaxosmithkline Biolog Sa |
Vaccine Corporation
|
|
EP2272522B1
(en)
|
2002-06-28 |
2017-09-06 |
Nestec S.A. |
Therapeutic compositions for use in prophylaxis or treatment of diarrheas
|
|
CA2508720A1
(en)
|
2002-12-03 |
2004-06-17 |
Dartmouth College |
Method to measure a t cell response and its uses to qualify antigen-presenting cells
|
|
AU2004227852B2
(en)
|
2003-03-31 |
2010-01-14 |
The Brigham And Women's Hospital, Inc. |
Zwitterionic immunomodulators for the treatment of asthma and allergy
|
|
US20060257852A1
(en)
|
2003-04-10 |
2006-11-16 |
Chiron Corporation |
Severe acute respiratory syndrome coronavirus
|
|
WO2005010215A2
(en)
|
2003-07-17 |
2005-02-03 |
Tolerrx, Inc. |
Methods for identifying tolerance modulatory compounds and uses therefor
|
|
US6846807B1
(en)
|
2003-07-25 |
2005-01-25 |
Board Of Regents, The University Of Texas System |
Colorectal neoplasia prophylaxis
|
|
AU2004267383A1
(en)
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Bacterial strains, compositions including same and probiotic use thereof
|
|
DE10353593A1
(de)
|
2003-11-17 |
2005-06-23 |
Klinikum der Universität München Großhadern-Innenstadt |
Leptinantagonist und Verfahren zur quantitativen Messung von Leptin
|
|
AU2004298983A1
(en)
|
2003-12-10 |
2005-06-30 |
Activbiotics, Inc. |
Rifamycin analogs and uses thereof
|
|
ATE539757T1
(de)
|
2004-11-02 |
2012-01-15 |
Univ Leland Stanford Junior |
Verfahren zur hemmung von nkt-zellen
|
|
US8426146B2
(en)
|
2005-06-03 |
2013-04-23 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Multiparameteric method for assessing immune system status
|
|
KR101300086B1
(ko)
|
2005-10-06 |
2013-08-30 |
프로비 아베 |
자가면역질환의 치료를 위한 락토바실러스의 용도
|
|
WO2007081447A2
(en)
|
2005-11-22 |
2007-07-19 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and sapovirus antigens
|
|
WO2007092451A2
(en)
|
2006-02-06 |
2007-08-16 |
The Brigham And Women's Hospital, Inc. |
Zwitterionic polysaccharides for promotion of immune system maturation and health
|
|
CN100366737C
(zh)
|
2006-03-01 |
2008-02-06 |
哈尔滨美华生物技术股份有限公司 |
固定化乳糖酶生产方法
|
|
WO2007106073A2
(en)
|
2006-03-02 |
2007-09-20 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
|
US20090252708A1
(en)
|
2006-05-18 |
2009-10-08 |
Biobalance Llc |
Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
|
|
ES2686593T3
(es)
|
2006-05-31 |
2018-10-18 |
The Regents Of The University Of California |
Expresión de CD127 que correlaciona inversamente con FoxP3 y la función supresora de Treg CD4+
|
|
PT103495B
(pt)
|
2006-06-05 |
2017-05-12 |
Faculdade De Farmácia Da Univ De Lisboa |
Pró-fármacos de ácidos orgânicos e composições farmacêuticas contendo os referidos pró-fármacos
|
|
EP2468300B1
(en)
|
2006-09-26 |
2017-12-20 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
PT2126054T
(pt)
|
2007-01-31 |
2016-10-12 |
Yeda Res & Dev |
Células t reguladoras geneticamente modificadas, redirecionadas e sua utilização na supressão de doenças inflamatórias e autoimunitárias
|
|
TW200904340A
(en)
|
2007-05-11 |
2009-02-01 |
Mannatech Inc |
Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
|
|
EP2165194A4
(en)
|
2007-05-31 |
2010-09-08 |
Abbott Lab |
BIOMARKERS FOR PREDICTING RESPONSABILITY TO TNF ALPHA INHIBITORS IN AUTOIMMUNE DISEASES
|
|
WO2009035738A2
(en)
|
2007-06-15 |
2009-03-19 |
University Of Rochester |
Use of antibody secreting cell elispot to assess antibody responses following antigen exposure
|
|
US8563523B2
(en)
*
|
2007-09-07 |
2013-10-22 |
University Of Georgia Research Foundation, Inc. |
Synthetic lipid A derivative
|
|
US20090124573A1
(en)
|
2007-11-09 |
2009-05-14 |
Sarkis Mazmanian |
Immunomodulating compounds and related compositions and methods
|
|
US20110002965A1
(en)
|
2007-11-09 |
2011-01-06 |
Round June L |
Immunomodulating compounds and related compositions and methods
|
|
TWI468188B
(zh)
|
2008-01-30 |
2015-01-11 |
Univ Tokushima |
Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
|
|
FR2930264B1
(fr)
|
2008-04-18 |
2013-02-22 |
Gervais Danone Sa |
Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices.
|
|
US8586029B2
(en)
|
2008-06-04 |
2013-11-19 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
WO2010025542A1
(en)
|
2008-09-05 |
2010-03-11 |
National Research Council Of Canada |
Lps based vaccines
|
|
US8911711B2
(en)
|
2008-09-30 |
2014-12-16 |
The Invention Science Fund I, Llc |
Method, device, and system to control pH in pulmonary tissue of a subject
|
|
EP2422200A4
(en)
|
2009-04-23 |
2013-02-27 |
California Inst Of Techn |
METHOD AND SYSTEMS FOR IDENTIFYING IMMUNOMODULATIVE SUBSTANCES
|
|
US20100311686A1
(en)
|
2009-06-03 |
2010-12-09 |
Kasper Lloyd H |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
|
US8580278B2
(en)
|
2009-06-03 |
2013-11-12 |
Trustees Of Dartmouth College |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
|
HUE040658T2
(hu)
|
2010-04-07 |
2019-03-28 |
California Inst Of Techn |
Vivõanyag vegyület mukózus membránhoz juttatásához és kapcsolódó készítmények, eljárások és rendszerek
|
|
WO2011146910A1
(en)
|
2010-05-20 |
2011-11-24 |
Round June L |
Antigen specific tregs and related compositions, methods and systems
|
|
CN102947441A
(zh)
|
2010-06-01 |
2013-02-27 |
穆尔研究企业有限责任公司 |
来自拟杆菌属的细胞组分、其组合物和使用拟杆菌或其细胞组分的治疗方法
|
|
US20140030807A1
(en)
|
2010-07-20 |
2014-01-30 |
Trustees Of Dartmouth College |
Method for stimulating foxp3+ regulatory t cell expression of cd39
|
|
WO2012048152A2
(en)
|
2010-10-07 |
2012-04-12 |
Mazmanian Sarkis K |
Probiotic therapies for autism
|
|
US20130064859A1
(en)
|
2011-01-28 |
2013-03-14 |
Sarkis K. Mazmanian |
Combinatorial vitamin d and probiotic therapy for inflammatory bowel disease
|
|
US9539281B2
(en)
*
|
2011-07-12 |
2017-01-10 |
The Brigham And Women's Hospital, Inc. |
Lipid-containing PSA compositions, methods of isolation and methods of use thereof
|
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
|
EP2763540A4
(en)
|
2011-09-09 |
2015-04-22 |
Univ Yale |
COMPOSITIONS AND METHODS FOR THE EVALUATION AND TREATMENT OF INFLAMMATORY DISEASES AND DISEASES
|
|
EP2764090B1
(en)
|
2011-10-03 |
2017-12-13 |
California Institute of Technology |
Generation of psa-only producing mutant strain
|
|
US20140072534A1
(en)
|
2012-08-30 |
2014-03-13 |
California Institute Of Technology |
Novel therapy for multiple sclerosis using vitamin d and gut bacteria
|
|
WO2014182966A1
(en)
|
2013-05-10 |
2014-11-13 |
California Institute Of Technology |
Probiotic prevention and treatment of colon cancer
|
|
AU2014388299A1
(en)
|
2014-03-25 |
2016-10-20 |
The Government Of The United States Of America As Represented By The Secretary Of The Army |
Methods for enhancing the immunostimulation potency of aluminum salt-adsorbed vaccines
|
|
CN108135167B
(zh)
|
2015-08-19 |
2021-07-09 |
哈佛学院院长及董事 |
脂化psa组合物和方法
|
|
WO2018014012A1
(en)
|
2016-07-15 |
2018-01-18 |
President And Fellows Of Harvard College |
Glycolipid compositions and methods of use
|